Spanish drugmaker Grifols reported on Wednesday a net profit ... expanding the company's product portfolio beyond its cosmetic injection Jeuveau. Healthcare & Pharmaceuticalscategory· February ...

It is already working with Novartis, Johnson & Johnson, and Grifols on projects ... multiple targeting and killing domains. The cash injection will help the company expand its R&D operations ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify early biological signals of Parkinson’s ...

It's time for an update on the Medical company Grifols, S.A. (NASDAQ:GRFS). It's been about 4 months since I last updated on the business, with that update being specific to an event where ...

The company said, “Building on the solid performance of 2024, Grifols (GRFS) forecasts continued success in 2025 with anticipated revenue growth and EBITDA expansion. Excluding the impact of the ...

BARCELONA, Feb 26 (Reuters) - Spanish drugmaker Grifols (GRLS.MC), opens new tab reported on Wednesday a net profit of 157 million euros ($165.02 million) for 2024 on revenues of 7.21 billion ...

Spanish drugmaker Grifols GRFS-Q said on Thursday it expects its revenue, core earnings and free cash flow to grow significantly in the coming years as it aims to leave behind a tumultuous 2024 ...

The net impact on the market is typically positive. Take Gotham City Research LLC’s dramatic assault on Grifols SA in January last year. The US hedge fund’s diatribe against the Spanish ...

Kepler Capital analyst Arnaud Girod maintained a Hold rating on Grifols SA (NASDAQ:GRFS) on Wednesday, setting a price target... Kepler Capital analyst Arnaud Girod maintained a Hold rating on ...

This page features the latest news about the Grifols Pref stock. Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton ...

Hamilton was declared a paid-plasma-free zone in June, but Canadian Blood Services and Spanish health-care company Grifols are going ahead anyway with the centre in a lower-income area at 2255 ...